Neurons use chemical 'chords' to shape signalingFebruary 28, 2008Researchers have discovered that neurons can use two different neurotransmitters that target the same receptor on a receiving neuron to shape the transmission of a nerve impulse. Although the researchers' experiments identified the "co-release" of the two neurotransmitters only in specific types of neurons in the brain's auditory center, their finding may apply more broadly in the brain, they said. Thus, the finding may represent a new way in which the brain precisely modulates the nerve impulses that travel from neuron to neuron in its circuitry. Tao Lu and colleagues Maria Rubio and Laurence Trussell reported their findings in the February 28, 2008, issue of the journal Neuron, published by Cell Press. To propagate a nerve impulse within neural circuitry, one neuron launches a burst of chemical signal called a neurotransmitter at a receiving neuron, where the neurotransmitter attaches to a specific receptor-like a key fitting a lock. That neurotransmitter-specific receptor is activated to trigger a nerve impulse in the receiving neuron. Such nerve impulses, however, rather than being the electrical equivalent of a shotgun blast, are precisely modulated signals, like the finely shaped notes of an orchestra. In studies over the past several decades, researchers had found evidence for co-release of different neurotransmitters by the same neuron. But they had assumed that in such cotransmission, each neurotransmitter targeted its own receptor on the receiving neuron. However, Lu and colleagues performed biochemical and electrophysiological experiments on rat neurons and established that two neurotransmitters-called GABA and glycine-both target the glycine receptor in specific types of neurons. The neurons they studied reside in the part of the rat auditory system that processes sound location. Thus, shaping the timing of the nerve impulse is important for such processing. Glycine acts as an inhibitory neurotransmitter in such neurons, and Lu and colleagues found that GABA acts on the glycine receptor to accelerate glycine-produced inhibition. Lu and colleagues wrote that, although their studies only establish the role of GABA/glycine cotransmission in the specialized auditory neurons, other studies had found evidence for cotransmission in other areas of the brain. Such findings hint that the two neurotransmitters may work in concert elsewhere "at a single receptor to enhance the temporal resolution of inhibition." "Of course, a hallmark of a great scientific study is the ability to approach an established problem from a fresh perspective," wrote Joshua Singer in a preview of the article in the same issue of Neuron. "And certainly the present work by Lu, Rubio, and Trussell characterizes this." Singer, who is at Northwestern University, asked, "Who would have thought that GABA [is a natural trigger for glycine receptors]" Not me, unfortunately." Cell Press |
|||||||||||||||||||||
| Related Neurotransmitter Current Events and Neurotransmitter News Articles Widely used cholesterol-lowering drug may prevent progression Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease. Benefit of memantine in the treatment of Alzheimer's disease not proven There is no scientific proof that patients with moderate or severe Alzheimer's disease benefit from drugs containing the agent memantine. Changes in brain chemicals mark shifts in infant learning When do you first leave the nest? Early in development infants of many species experience important transitions-such as learning when to leave the protective presence of their mother to start exploring the wider world. Why antidepressants don't work for so many More than half the people who take antidepressants for depression never get relief. Now hear this Deep in the ear, 95 percent of the cells that shuttle sound to the brain are big, boisterous neurons that, to date, have explained most of what scientists know about how hearing works. Popular antidepressant associated with a dramatic increase in suicidal thoughts amongst men Nortriptyline has been found to cause a ten-fold increase in suicidal thoughts in men when compared to its competitor escitalopram. These findings are published in the open access journal BMC Medicine. Study supports possible role of urate in slowing Parkinson's disease progression By examining data from a 20-year-old clinical trial, a research team based at the MassGeneral Institute for Neurodegenerative Diseases (MGH-MIND) and Harvard School of Public Health (HSPH), has found evidence supporting the findings of their 2008 study - that elevated levels of the antioxidant urate may slow the progression of Parkinson's disease. Michigan hospital launches gene therapy study for Parkinson's disease A Michigan hospital is embarking on a research study for advanced Parkinson's disease using a state-of-the-art treatment called gene transfer. Why one way of learning is better than another A new study from the Montreal Neurological Institute and Hospital (The Neuro) of McGill University reveals that different patterns of training and learning lead to different types of memory formation. Researchers find a key mechanism in the development of nerve cells Chaos brews in the brains of newborns: the nerve cells are still bound only loosely to each other. More Neurotransmitter Current Events and Neurotransmitter News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||